SCHEMBL66186

SCHEMBL66186

CN1CCNC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL457607 1.00
Hydrochloric Acid SCHEMBL19025652 0.97
SCHEMBL9246375 0.97 SOS1 (0.31)
Water SCHEMBL8209108 0.97
SCHEMBL15375649 0.97
Lithium Ion SCHEMBL16667619 0.97
Lithium SCHEMBL31498829 0.97
SCHEMBL27447117 0.94 PHGDH (0.36)
SCHEMBL28716639 0.87
SCHEMBL23519194 0.85

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1410 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260137650-A1 MODULATORS OF RAR RELATED ORPHAN RECEPTORS (RORs) 11949098 CANADA INC (CA) 2026-05-21 US claimed
EP-4709383-A1 INVERSE AGONISTS OF RAR RELATED ORPHAN RECEPTORS (RORS) 11949098 Canada Inc. (CA) 2026-03-18 EP claimed
WO-2025097247-A1 METHOD OF TREATMENT OF FIBROSIS WITH INVERSE AGONIST OF RAR RELATED ORPHAN RECEPTORS (RORS) 11949098 CANADA INC. (CA) 2025-05-15 WO claimed
WO-2024229569-A9 INVERSE AGONISTS OF RAR RELATED ORPHAN RECEPTORS (RORS) 11949098 CANADA INC. (CA) 2025-01-30 WO claimed
WO-2024229569-A1 INVERSE AGONISTS OF RAR RELATED ORPHAN RECEPTORS (RORS) 11949098 CANADA INC. (CA) 2024-11-14 WO claimed
CN-118290322-A Aromatic molecules for the treatment of pathological conditions 赛尼欧普罗有限责任公司 2024-07-05 CN claimed
WO-2024104425-A1 KRAS INHIBITOR COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF 广东东阳光药业股份有限公司 2024-05-23 WO claimed
CN-118047801-A KRAS inhibitor compound, pharmaceutical composition and application thereof 广东东阳光药业股份有限公司 2024-05-17 CN claimed
US-20240140895-A1 NOVEL AROMATIC MOLECULES Xeniopro GmbH (DE) 2024-05-02 US claimed
US-20230399304-A1 COVALENT INHIBITORS OF CREATINE KINASE (CK) AND USES THEREOF FOR TREATING AND PREVENTING CANCER DANA-FARBER CANCER INSTITUTE, INC. 2023-12-14 US claimed
WO-1992000273-A1 ORTHOSUBSTITUTED BIPHENYL AMIDINE AND BIPHENYL GUANIDINE DERIVATIVES AND ANTIDIABETIC OR HYPOGLYCAEMIC AGENTS CONTAINING THEM THE BOOTS COMPANY PLC (GB) 1992-01-09 WO claimed
WO-1991014687-A1 2-(SUBSTITUTED PYRROLIDINYLTHIO)CARBAPENEM DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 1991-10-03 WO claimed
EP-0449191-A1 2-(Substituted pyrrolidinylthio)carbapenem derivatives Banyu Pharmaceutical Co., Ltd. (JP) 1991-10-02 EP claimed
EP-0385038-A1 Ortho-substituted phenyl amidine and phenyl guanidine derivatives and antidiabetic or hypoglycaemic agents containing them The Boots Company PLC (GB) 1990-09-05 EP claimed
US-4954494-A Cardiotonic and inotropic agents RORER PHARMACEUTICAL CORPORATION (US) 1990-09-04 US claimed
US-4925901-A STORAGE STAABILITY, ONIUM ION CATALYST THE DOW CHEMICAL COMPANY (US) 1990-05-15 US claimed
US-4868300-A INOTROPIC AGENTS, CONGESTIVE HEART FAILURE RORER PHARMACEUTICAL CORPORATION (US) 1989-09-19 US claimed
US-4826835-A INOTROPIC AGENTS RORER PHARMACEUTICAL CORPORATION (US) 1989-05-02 US claimed
US-4216332-A FROM N,N-DIMETHYLAMINO ACETONITRILE AND CHLORINE GAS BAYER AKTIENGESELLSCHAFT (DE) 1980-08-05 US claimed
US-4105657-A PRODUCTION OF N-ALKYL DERIVATIVES OF CYCLIC ALKYLENIMINES BASF AKTIENGESELLSCHAFT (DE) 1978-08-08 US claimed